Leukemia-fighting gene therapy has ups (it usually works) and downs ($475K price, brutal side effects) – The Mercury News
The Mercury News |
Leukemia-fighting gene therapy has ups (it usually works) and downs ($475K price, brutal side effects)
The Mercury News This photo provided by the Children’s Hospital of Philadelphia, taken in May 2017, shows Emily Whitehead five years after she became the first pediatric patient in the world to receive an experimental therapy at the hospital that has put her leukemia … US clears breakthrough gene therapy for childhood leukemiaABC News First Gene Therapy Treatment Approved in USSmithsonian FDA approves a ‘historic’ new type of leukemia treatmentToday.com FDA.gov –National Cancer Institute –Novartis all 491 news articles » |
The Mercury News |
Leukemia-fighting gene therapy has ups (it usually works) and downs ($475K price, brutal side effects)
The Mercury News This photo provided by the Children’s Hospital of Philadelphia, taken in May 2017, shows Emily Whitehead five years after she became the first pediatric patient in the world to receive an experimental therapy at the hospital that has put her leukemia … US clears breakthrough gene therapy for childhood leukemiaABC News First Gene Therapy Treatment Approved in USSmithsonian FDA approves a ‘historic’ new type of leukemia treatmentToday.com FDA.gov –National Cancer Institute –Novartis all 491 news articles » |
|
Intrexon to Participate in Upcoming Investor Conferences
Markets Insider … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. With Shares Trading up at $19.73 (XON) Intrexon to Participate in Upcoming…First News 24 |
|
Intrexon to Participate in Upcoming Investor Conferences
Markets Insider … delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. (XON) With Shares Trading up at $19.73 Intrexon to Participate in Upcoming…Modern Readers |
|
First gene therapy to treat deadly cancer approved in US
Greater Kashmir The patient’s T-cells are collected and sent to a manufacturing centre where they are genetically modified to include a new gene that contains a specific protein (a chimeric antigen receptor or CAR) that directs the T-cells to target and kill leukaemia … |
KING5.com |
Investors are betting on a cancer cure with these stocks
CNBC CAR-T cell therapy is a form of immunotherapy, a rapidly developing cancer treatment that uses patients’ own immune cells to attack tumors. In contrast, the typical, less efficient method of treating cancer uses combinations of surgery, chemotherapy … FDA approves the first immunotherapy drug for childhood leukemiaKING5.com FDA approval brings first gene therapy to the United StatesFDA.gov Landmark FDA approval clears the way for gene therapy treatments that fight cancerGeekWire PR Newswire (press release) –Telegraph.co.uk –Reuters all 418 news articles » |
FierceBiotech |
News of Note—Gene therapy to protect the heart; boosting chemo with cardio drugs; reversing memory loss
FierceBiotech Scientists at the University of California at Los Angeles and the Howard Hughes Medical Institute reported that they successfully used gene therapy to lower cholesterol in mouse models of familial hypercholesterolemia. The gene they used, called LeXis … |